What's New
WIRED
The latest in-depth coverage covering the intersection of technology and culture will help you make sense of a world in constant transformation. Join us as we explore the ways technology is changing our lives.
Episodes
Mentioned books
Nov 30, 2020 • 2min
The AstraZeneca Covid vaccine data isn't up to snuff – Tech in Two
Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt
Learn about your ad choices: dovetail.prx.org/ad-choices
Nov 25, 2020 • 3min
What's Wrong with AstraZeneca's Trial Results—Most Interesting Thing in Tech
Earlier this week, AstraZeneca and Oxford released early vaccine trial results. At first they looked good! But it's become clear they're a long way off from proving their vaccine is ready to go. More here: https://www.wired.com/story/the-astrazeneca-covid-vaccine-data-isnt-up-to-snuff/.
Learn about your ad choices: dovetail.prx.org/ad-choices
Nov 25, 2020 • 2min
How to make multiple smart speakers work together – Tech in Two
Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt
Learn about your ad choices: dovetail.prx.org/ad-choices
Nov 24, 2020 • 5min
Battles Over Facebook's News Feed Algorithm—Most Interesting Thing in Tech
Facebook, it seems, has figured out algorithmic changes that could reduce misinformation and disinformation and make democracy work better. But will they implement them? There are complicated tradeoffs and an internal battle at the company.
Learn about your ad choices: dovetail.prx.org/ad-choices
Nov 24, 2020 • 2min
AstraZeneca announces its vaccine is effective, pharmaceutical and manufacturing companies work on “ultra-cold” distribution solutions, and Ad Council begins a campaign to boost vaccine trust — Tech in Two
Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt
Learn about your ad choices: dovetail.prx.org/ad-choices
Nov 23, 2020 • 3min
GM Starts Selling Car Insurance—Most Interesting Thing in Tech
General Motors is now offering its own car insurance, based on data from your cars. I like this! I want a more efficient car-insurance market, and it shows, yet again, that, in the future, car companies won’t just be selling you vehicles—they’ll also be trying to figure out smart things about the data of everyone who uses them.
Learn about your ad choices: dovetail.prx.org/ad-choices
Nov 23, 2020 • 2min
Pfizer seeks FDA approval for its vaccine, the CDC urges Americans to avoid Thanksgiving travel, and the federal pandemic response draws renewed concern – Tech in Two
Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt
Learn about your ad choices: dovetail.prx.org/ad-choices
Nov 20, 2020 • 3min
Robots Come to Construction—Most Interesting Thing in Tech
Robotics and innovation are coming to construction, an industry that has been disrupted by tech much less than I had thought. More here: https://www.wired.com/story/robots-invade-construction-site/.
Learn about your ad choices: dovetail.prx.org/ad-choices
Nov 20, 2020 • 2min
A cancer patient's search for the DNA data that could save his life — Tech in Two
Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt
Learn about your ad choices: dovetail.prx.org/ad-choices
Nov 19, 2020 • 2min
Pfizer releases more promising news, the FDA approves the first at-home test, and Larry Brilliant offers his pandemic forecast — Tech in Two
Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt
Learn about your ad choices: dovetail.prx.org/ad-choices
